Compare · PLUS vs WGS
PLUS vs WGS
Side-by-side comparison of ePlus inc. (PLUS) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PLUS and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- WGS is the larger of the two at $2.46B, about 1.1x PLUS ($2.27B).
- Over the past year, PLUS is up 22.5% and WGS is down 31.5% - PLUS leads by 54.0 points.
- PLUS has been more active in the news (11 items in the past 4 weeks vs 7 for WGS).
- WGS has more recent analyst coverage (8 ratings vs 3 for PLUS).
- Company
- ePlus inc.
- GeneDx Holdings Corp.
- Price
- $86.76+0.44%
- $82.70+3.79%
- Market cap
- $2.27B
- $2.46B
- 1M return
- -1.10%
- +32.09%
- 1Y return
- +22.49%
- -31.47%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1996
- 2020
- News (4w)
- 11
- 7
- Recent ratings
- 3
- 8
ePlus inc.
ePlus inc., through its subsidiaries, provides information technology solutions that enable organizations to optimize their information technology (IT) environment and supply chain processes in the United States. It operates in two segments, Technology and Financing. The Technology segment offers hardware, perpetual and subscription software, maintenance, software assurance, and internally-provided and outsourced services; and professional and managed services, including ePlus managed, professional, security, ePlus Cloud Consulting, staff augmentation, server and desktop support, and project management services. The Financing segment specializes in leasing and financing arrangements, such as sales-type and operating leases; loans and consumption-based financing arrangements; and underwriting and management of IT equipment and assets. Its financing operations comprise sales, pricing, credit, contracts, accounting, risk management, and asset management. This segment primarily finances IT, communication-related, and medical equipment; and industrial machinery and equipment, office furniture and general office equipment, transportation equipment, and other general business equipment directly, as well as through vendors. ePlus inc. serves commercial entities, state and local governments, government contractors, and educational institutions. The company was formerly known as MLC Holdings, Inc. and changed its name to ePlus inc. in 1999. ePlus inc. was founded in 1990 and is headquartered in Herndon, Virginia.
Latest PLUS
- Director Callies John E sold $44,043 worth of shares (500 units at $88.09), decreasing direct ownership by 2% to 20,648 units (SEC Form 4)
- CHIEF OPERATING OFFICER Raiguel Darren S sold $90,827 worth of shares (1,000 units at $90.83) as part of a pre-agreed trading plan (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by ePlus inc.
- CHIEF OPERATING OFFICER Raiguel Darren S sold $19,600 worth of shares (200 units at $98.00) as part of a pre-agreed trading plan (SEC Form 4)
- CHIEF FINANCIAL OFFICER Marion Elaine D sold $690,286 worth of shares (7,182 units at $96.11) as part of a pre-agreed trading plan (SEC Form 4)
- ePlus inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- SEC Form 10-Q filed by ePlus inc.
- ePlus Reports First Quarter Fiscal Year 2027 Financial Results
- CHIEF FINANCIAL OFFICER Marion Elaine D sold $268,337 worth of shares (2,818 units at $95.22) as part of a pre-agreed trading plan (SEC Form 4)
- CHIEF OPERATING OFFICER Raiguel Darren S sold $188,065 worth of shares (2,000 units at $94.03) as part of a pre-agreed trading plan (SEC Form 4)
Latest WGS
- SEC Form SCHEDULE 13G filed by GeneDx Holdings Corp.
- GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
- Amendment: SEC Form SCHEDULE 13G/A filed by GeneDx Holdings Corp.
- GeneDx to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports Second Quarter 2026 Financial Results
- SEC Form 25-NSE filed by GeneDx Holdings Corp.
- GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
- SEC Form 4 filed by President Gardner Mark A